RESEARCH - Prevalence of IBS and depression in fibromyalgia

[Guest guest]

Prevalence of irritable bowel syndrome and depression in fibromyalgia

Jayde E. Kurland1, 4 , Walter J. Coyle1, Anne Winkler2 and Zable3

(1) Department of Gastroenterology, Naval Medical Center San Diego,

San Diego, California

(2) St. 's Physicians and Clinics, Springfield, Missouri

(3) University Community Hospital, Tampa, Florida, USA

(4) 1116 Reserve Champion Dr., Rockville, MD, 20850

Received: 7 June 2005 Accepted: 11 August 2005

Abstract The purpose of this study was to determine the point

prevalence of depressive symptoms, using the PRIME-MD questionnaire,

and irritable bowel syndrome (IBS), while comparing the Rome II to the

Rome I criteria, in patients with fibromyalgia (FM) and rheumatologic

controls in an outpatient setting. The prevalence of IBS in FM

patients (n = 105) was 63% by Rome I and 81% by Rome II criteria. The

prevalence of IBS in controls (n = 62) was 15% by Rome I and 24% by

Rome II criteria (FM vs. control; P < 0.001). Depressive symptoms were

met in 40% of FM patients and 8% of controls (P < 0.001). The

coexistence of IBS and depressive symptoms in the FM patients was 31%

(Rome I) and 34% (Rome II). The prevalence of IBS and depressive

symptoms was higher in FM patients compared to the control population.

Identification of IBS and depressive symptoms in FM patients might

enable clinicians to better meet the needs of this patient population.

http://www.springerlink.com/content/75374r076q6x471j/

--

Not an MD